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Abstract. 
 
Ciliary neurotrophic factor (CNTF), leuke-
mia inhibitory factor (LIF), cardiotrophin-1 (CT-1), and 
interleukin 6 (IL-6) comprise a group of structurally re-
lated cytokines that promote the survival of subsets of 
neurons in the developing peripheral nervous system, 
but the signaling pathways activated by these cytokines 
that prevent neuronal apoptosis are unclear. Here, we 
show that these cytokines activate NF-
 
k
 
B in cytokine-
dependent developing sensory neurons. Preventing NF-
 
k
 
B activation with a super-repressor I
 
k
 
B-
 
a
 
 protein 
markedly reduces the number of neurons that survive 
in the presence of cytokines, but has no effect on the 
survival response of the same neurons to brain-derived 
neurotrophic factors (BDNF), an unrelated neu-
rotrophic factor that binds to a different class of recep-
tors. Cytokine-dependent sensory neurons cultured 
from embryos that lack p65, a transcriptionally active 
subunit of NF-
 
k
 
B, have a markedly impaired ability to 
survive in response to cytokines, but respond normally 
to BDNF. There is increased apoptosis of cytokine-
dependent neurons in 
 
p65
 
2
 
/
 
2
 
 embryos in vivo, resulting 
in a reduction in the total number of these neurons 
compared with their numbers in wild-type embryos. 
These results demonstrate that NF-
 
k
 
B plays a key role 
in mediating the survival response of developing neu-
rons to cytokines.
Key words: leukemia inhibitory factor • ciliary neuro-
trophic factor • cardiotrophin-1 • apoptosis • neuron
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Introduction
 
Nuclear factor kappa
 
 
 
B (NF-
 
k
 
B)
 
1
 
 is a ubiquitously ex-
pressed transcription factor that consists of homodimers
or heterodimers of a family of structurally related proteins
(Baldwin, 1996; Ghosh et al., 1998). In most cell types, it is
present as a heterodimer comprising p65 (RelA) and p50
subunits, which is held in an inactive form in the cytosol by
interaction with a member of the I
 
k
 
B family of inhibitory
proteins (Verma and Stevenson, 1997; Karin, 1998). NF-
 
k
 
B
is activated by the phosphorylation and subsequent degra-
dation of I
 
k
 
B, which results in translocation of the liber-
ated NF-
 
k
 
B to the nucleus where it induces transcription
of target genes. A wide variety of noxious stimuli, such as
viral and bacterial infection, UV light, ionizing radiation,
and free radicals, as well as a variety of lymphokines and
cytokines, activate NF-
 
k
 
B which in turn positively regu-
lates the expression of genes that mediate an acute inflam-
matory response (Baldwin, 1996; Baeuerle and Baichwal,
1997). In addition, NF-
 
k
 
B activation suppresses apoptosis
induced by tumor necrosis factor (TNF) and various geno-
toxic agents in lymphoid and fibroblast cell lines (Beg and
Baltimore, 1996; Van Antwerp et al., 1996; Wang et al.,
1996) and protects hippocampal neurons against oxidative
stress-induced apoptosis (Mattson et al., 1997). These data
and the finding that there is massive hepatocyte death in
 
p65
 
2
 
/
 
2
 
 mouse embryos (Beg et al., 1995) indicate that
NF-
 
k
 
B also plays a role in regulating cell survival.
In the nervous system, NF-
 
k
 
B is not only involved in
mediating inflammatory responses (O’Neill and Kalt-
schmidt, 1997), but is induced by several molecules that
play key roles in neural function and development. For
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example, NF-
 
k
 
B is induced by glutamate in cerebellar
granule cells (Guerrini et al., 1995; Kaltschmidt et al.,
1995), by nerve growth factor (NGF) in Schwann cells
(Carter et al., 1996), and NGF-dependent sympathetic and
sensory neurons (Maggirwar et al., 1998; Hamanoue et al.,
1999). In the case of Schwann cells and sensory neurons, it
has been shown that NGF activates NF-
 
k
 
B by binding to
the p75 neurotrophin receptor (Carter et al., 1996; Ha-
manoue et al., 1999). Although p75 is not essential for the
survival response of neurons to NGF, binding of NGF to
this receptor in neurons coexpressing the NGF receptor
tyrosine kinase, TrkA, significantly enhances the number
of neurons that survive (Davies et al., 1993; Lee et al.,
1994; Horton et al., 1997; Ryden et al., 1997). Preventing
NF-
 
k
 
B activation in NGF-treated sensory neurons causes
a modest reduction in survival, suggesting that the p75-
mediated enhancement of the NGF survival response is at
least partly due to NF-
 
k
 
B activation (Hamanoue et al.,
1999). Likewise, preventing NF-
 
k
 
B activation in NGF-
treated sympathetic neurons reduces the survival of these
neurons (Maggirwar et al., 1998).
In addition to the neurotrophins (NGF, brain-derived
neurotrophic factor [BDNF], neurotrophin 3 [NT-3], and
NT-4), several other families of neurotrophic factors play
key roles in promoting and regulating neuronal survival.
Ciliary neurotrophic factor (CNTF), leukemia inhibitory
factor (LIF), cardiotrophin-1 (CT-1), and interleukin-6
(IL-6) comprise a family of cytokines that have multiple
actions on cells of the nervous system and promote the
survival of various kinds of neurons during development
(Sendtner et al., 1994; Stahl and Yancopoulos, 1994).
Although there is 
 
,
 
15% amino acid sequence identity
between these factors, they share several characteristic
structural features (Bazan, 1991; Robinson et al., 1994;
McDonald et al., 1995) and signal via oligomeric receptor
complexes that have one or more components in com-
mon (Davis et al., 1993; Stahl et al., 1994; Wollert et
al.,  1996). The transmembrane glycoproteins gp130 and
LIFR
 
b
 
 are common components of the receptor com-
plexes for CNTF, LIF, oncostatin M (OSM), and CT-1.
The CNTF receptor complex has an additional GPI-linked
CNTFR
 
a
 
 subunit, and the IL-6 receptor consists of two
gp130 subunits and an IL-6R
 
a
 
 subunit. Binding of these
cytokines to their receptor complexes results in the direct
or indirect activation of several signaling pathways includ-
ing the JAK-Stat, PI-3 kinase, Ras/MAP kinase, and PLC-
 
g
 
pathways (Boulton et al., 1994; Stahl et al., 1994; Frank
and Greenberg, 1996).
To further investigate the role of NF-
 
k
 
B in regulating
neuronal survival, we measured and experimentally ma-
nipulated NF-
 
k
 
B activation in populations of sensory
neurons that survive in response to cytokines. Neurons
from the trigeminal and nodose ganglia of embryonic day
18 (E18) mouse embryos were used for these studies be-
cause their large size facilitates microinjection of con-
structs used for measuring and manipulating NF-
 
k
 
B acti-
vation. These neurons are supported by neurotrophic
cytokines in culture and die by apoptosis after neu-
rotrophic factor deprivation
 
 
 
(Horton et al., 1998). We
show that NF-
 
k
 
B activation plays a major role in mediat-
ing the survival response of these neurons to neurotrophic
cytokines.
 
Materials and Methods
 
Neuron Culture, Microinjection, and Survival Assays
 
For microinjection studies, dissociated cultures of trigeminal and nodose
ganglion neurons were established from E18 CD1 embryos. The dissected
ganglia were trypsinized and dissociated by trituration, and the neurons
were purified free of nonneuronal cells by differential sedimentation
(Davies, 1986). The neurons (
 
.
 
95% pure) were grown in defined, serum-
free medium on a poly-ornithine/laminin substratum in 60-mm diam tissue
culture petri dishes (Davies et al., 1993). After an initial 12–24-h incuba-
tion period with a neurotrophic factor that promotes survival, the neurons
were washed extensively to remove this factor and were injected intranu-
clearly (Allsopp et al., 1993) with pcDNAIII expression plasmids. The
pcDNAIII plasmid without a cDNA insert was used to control for nonspe-
cific effects of the injection procedure, and pcDNAIII plasmids containing
cDNAs encoding the human p65 NF-
 
k
 
B subunit or a mutated I
 
k
 
B-
 
a
 
 that
is defective in signal-induced degradation (Rodriguez et al., 1996) were
used to investigate the role of NF-
 
k
 
B activation in promoting neuronal
survival. The expression plasmids were diluted in 100 mM potassium
phosphate buffer, pH 7, to a concentration of 100 
 
m
 
g/ml and filtered
through a 0.22-
 
m
 
m filter before injection. Some cultures were resupple-
mented with neurotrophic factor 30 min after injection. The number of
surviving neurons was counted at 24 hourly intervals after injection and is
expressed as a percentage of the number injected. About 150 neurons
were injected for each experimental condition.
For studies of the endogenous p65 on neuronal survival, cultures were
established from mice that have a null mutation in the 
 
p65
 
 gene (a gift of
Amer Beg and David Baltimore (Beg et al., 1995). Heterozygous mice
were crossed to obtain 
 
p65
 
2
 
/
 
2
 
, 
 
p65
 
1
 
/
 
2
 
 and 
 
p65
 
1
 
/
 
1
 
 embryos. After 12- or
14-d gestation, the pregnant females were killed and nodose ganglia were
dissected from each embryo separately. After genotyping the embryos by
a PCR based method, the ganglia of each genotype were pooled and low-
density, dissociated cultures were established. The neurons were grown in
defined medium in laminin/poly-ornithine coated petri dishes with a range
of concentrations of CNTF, LIF, CT-1, IL-6, or BDNF as described
above. The number of neurons surviving after 48-h incubation is ex-
pressed as a percentage of the number of attached neurons counted 6 h af-
ter plating.
 
Measurement of NF-
 
k
 
B Activation
 
E18 trigeminal neurons were grown for 24 h with 2 ng/ml NGF, washed
thoroughly to remove the NGF, and incubated in F14 medium for a fur-
ther 2 h before being injected with two DNA constructs: an NF-
 
k
 
B–
dependent luciferase reporter gene that consists of three synthetic copies
of the NF-
 
k
 
B–consensus sequence from the Ig-
 
k
 
 chain promoter upstream
of the luciferase gene (Rodriguez et al., 1996) and a lacZ gene that is
driven by an RSV promoter. In some experiments, neurons were also
coinjected with the mutated I
 
k
 
B-
 
a
 
 expression plasmid. Injected neurons
were harvested using a rubber policeman 6 h later. Several hundred neu-
rons were injected for each assay. The cultures were treated with 50 ng/ml
CNTF 30 min after injection; untreated cultures served as controls. Lu-
ciferase activity was measured by using a luminometer as described previ-
ously (Rodriguez et al., 1996) and 
 
b
 
-galactosidase activity was measured
by using the Galactolight kit (Tropix) as recommended by the manufac-
turer. The relative level of NF-
 
k
 
B activation in each experiment was cal-
culated by dividing the luciferase activity by 
 
b
 
-galactosidase activity.
 
Quantification of the Number of Neurons in the
Nodose Ganglia
 
E14 mouse embryos in litters resulting from overnight matings of 
 
p65
 
1
 
/
 
2
 
mice were fixed in Carnoy’s fluid (60% ethanol, 30% chloroform, 10%
acetic acid) for 20 min before dehydration and wax-embedding. Serial sec-
tions of the heads were cut at 8 
 
m
 
m, mounted on poly lysine-coated slides,
and cleared in xylene and dehydrated before quenching (10% methanol,
3% hydrogen peroxide in PBS). To identify all neurons in these prepara-
tions, the sections were stained for neurofilament protein as described
previously (Middleton et al., 1998). In addition, the sections were counter-
stained with cresyl fast violet to permit identification of pyknotic nuclei.
Estimation of neuronal number was carried out as described previously
(Piñón et al., 1996) using the Abercrombie method to correct for split nu-
clei (Abercrombie, 1946). Pyknotic nuclei were recognized as one or more 
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darkly stained spherical structures contained within a clearly visible mem-
brane (Piñón et al., 1996).
 
Immunocytochemical Detection of Cytokine Receptors 
on Nodose Neurons
 
To ascertain if the 
 
p65
 
 null mutation affects the expression of cytokine re-
ceptors on nodose neurons, immunocytochemistry was used to assess the
proportion of neurons that express cytokine receptor components in cul-
tures established from the nodose ganglia of E12 and E14 wild-type 
 
p65
 
1
 
/
 
2
 
and 
 
p65
 
2
 
/
 
2
 
 embryos. Dissociated cultures of nodose neurons were cul-
tured with a cocktail of neurotrophic factors (50 ng/ml CNTF, 50 ng/ml
LIF, 50 ng/ml CT-1, and 10 ng/ml BDNF) to sustain the survival of the
maximum number of neurons. 6 h after plating, the cultures were fixed for
15 min in neutral buffered formalin. After washing with PBS, endogenous
peroxidase activity was quenched with 1% hydrogen peroxidase in metha-
nol. After 20 min incubation in PBS containing 0.5% Triton X-100 and
10% serum (rabbit serum for goat primary antibody and goat serum for
rabbit primary antibody), the cultures were incubated for 1 h at room tem-
perature in 1:300 dilution of one of the following antibodies: rabbit anti-
gp130, rabbit anti-LIFR
 
b
 
, goat anti-CNTFR
 
a
 
, and rabbit anti-IL-6R
 
a
 
 (all
from Santa Cruz). After washing with PBS, bound primary antibodies
were labeled using biotinylated secondary antibody (1:200), avidin, and
biotinylated HRP macromolecular complex (Vectastain ABC Kit, Vector
Laboratories). The substrate used for the peroxidase reaction was 1 mg/ml
diaminobenzidine tetrachloride (Sigma Chemical Co.). The number of la-
beled neurons was assessed by bright-field illumination on an inverted mi-
croscope.
 
Results
 
CNTF Activates NF-
 
k
 
B
 
To ascertain whether neurotrophic cytokines activate NF-
 
k
 
B
in neurons, we microinjected neurotrophic factor-deprived
neurons with an NF-
 
k
 
B–dependent luciferase reporter
construct (Rodriguez et al., 1996) and assayed luciferase
activity after cytokine treatment. Because relatively large
numbers of neurons have to be injected to produce a
clearly quantifiable signal, we used trigeminal neurons for
these studies because the trigeminal ganglia are by far the
largest ganglia in the peripheral nervous system of the
mouse embryo. These studies were carried out at E18
because trigeminal neurons display a clear survival re-
sponse to CNTF at this stage (Horton et al., 1998) and
have grown to a sufficiently large size to facilitate microin-
jection. To standardize luciferase activity measurements
between experiments, we coinjected a lacZ gene driven
by a constitutive RSV promoter and additionally assayed
for 
 
b
 
-galactosidase activity. Separate experiments showed
that 
 
b
 
-galactosidase activity was unaffected by CNTF
(data not shown). Fig. 1 shows that five hours after CNTF
treatment, the relative luciferase activity was fourfold
higher than in untreated control cultures, indicating that
CNTF activates NF-
 
k
 
B in these neurons. The activity of a
control luciferase reporter lacking NF-
 
k
 
B binding sites
was unchanged by treatment with CNTF (data not shown).
To determine if the rise in luciferase activity after CNTF
treatment was a direct consequence of NF-
 
k
 
B–dependent
transcription, the NF-
 
k
 
B–dependent luciferase reporter
was coinjected with a plasmid that expresses a super-
repressor form of the NF-
 
k
 
B inhibitor, I
 
k
 
B-
 
a
 
. This I
 
k
 
B-
 
a
 
protein associates normally with NF-
 
k
 
B, but carries ser-
ine-to-alanine mutations at residues 32 and 36 that pre-
vents signal modification and proteosome-mediated deg-
radation, thereby preventing release and translocation of
NF-
 
k
 
B to the nucleus (Rodriguez et al., 1996; Roff et al.,
1996). This super-repressor I
 
k
 
B-
 
a
 
 completely abolished
the rise in luciferase activity after treatment with CNTF
(Fig. 1), indicating that this rise was due to NF-
 
k
 
B–depen-
dent transcription.
 
NF-
 
k
 
B Activation Plays a Role in Mediating the 
Cytokine Survival Response
 
Having ascertained that CNTF activates NF-
 
k
 
B, we inves-
tigated whether preventing NF-
 
k
 
B activation would inter-
fere with the CNTF survival responses. Injection of the
super-repressor I
 
k
 
B-
 
a
 
 expression plasmid into E18 tri-
geminal neurons caused a highly significant reduction in
the number of neurons surviving with CNTF, compared
with neurons injected with an empty expression plasmid
(
 
P
 
 
 
, 
 
0.0001, 
 
t
 
 test; Fig. 2). These results suggest that the
survival response of trigeminal neurons to CNTF is medi-
ated to a large extent by the activation of NF-
 
k
 
B.
Because nodose ganglion neurons are more responsive
to cytokines than trigeminal neurons (Horton et al., 1998),
we extended our analysis of the antiapoptotic function of
NF-
 
k
 
B to this population of sensory neurons. Fig. 3 shows
that injection of E18 nodose neurons with the super-
repressor I
 
k
 
B-
 
a
 
 expression plasmid markedly reduced the
number of neurons surviving with CNTF, CT-1, and LIF,
compared with neurons injected with an empty expression
plasmid (
 
P
 
 
 
, 
 
0.0001 in all cases, 
 
t
 
 tests). The percentage
reduction in survival ranged from 45% with LIF to 62%
with CNTF. In contrast, injection of nodose neurons with
the super-repressor I
 
k
 
B-
 
a
 
 expression plasmid had no ef-
fect on the survival response of these neurons to BDNF
(Fig. 3). This not only clearly indicates that expression of
super-repressor I
 
k
 
B-
 
a
 
 does not exert a nonspecific detri-
mental effect on neuronal survival, but shows that NF-
 
k
 
B
Figure 1. Bar chart of rela-
tive NF-kB activation (lu-
ciferase activity divided by
b-galactosidase activity) in
E18 trigeminal neurons un-
der different experimental
conditions. The neurons
were initially cultured with
NGF for 24 h, washed, and
incubated in NGF-free me-
dium for 2 h, then coinjected
with the NF-kB–dependent
luciferase reporter construct
and the RSV lacZ expression
plasmid (plus the super-
repressor IkB-a expression
plasmid in the cultures indi-
cated), and maintained for a
further 6 h before assaying
for luciferase and b-galac-
tosidase activities. CNTF (50
ng/ml) was added to the cul-
tures indicated immediately
after injection. Relative
NF-kB activity at each point
is calculated from the ratio of luciferase to lacZ activity com-
pared with the untreated control. The mean and SEM are shown
for three separate experiments.The Journal of Cell Biology, Volume 148, 2000 328
activation plays a highly selective role in mediating neu-
rotrophic factor responses.
To confirm that NF-kB activation independent of cyto-
kine treatment could sustain the survival of neurotrophic
factor-deprived nodose neurons, we microinjected a plas-
mid expressing the transcriptionally active p65 subunit of
NF-kB into neurotrophic factor-deprived nodose neurons.
In these experiments, cultures of purified nodose neurons
were first incubated for 24 h in LIF-supplemented me-
dium. The neurons were then deprived of LIF by extensive
washing and injected with the p65 expression plasmid or
an empty plasmid to control for the injection procedure.
Counts of surviving neurons made at 24 hourly intervals
after injection revealed that virtually all neurotrophic fac-
tor-deprived neurons injected with the empty expression
plasmid had died after 72 h, whereas a large proportion of
p65 overexpressing neurons survived at all time points
(Fig. 4). Coinjection of the super-repressor IkB-a plasmid
with the p65 plasmid completely prevented the antiapop-
totic function of overexpressed p65 (data not shown), indi-
cating that exogenous p65 prevented apoptosis as a direct
consequence of NF-kB activation. Neurons that were re-
supplemented with LIF or CNTF survived better than
neurotrophic factor-deprived neurons overexpressing p65
(Fig. 4), suggesting that NF-kB activation may not be suffi-
cient to account for the full survival-promoting effects of
these cytokines, as suggested in the data shown in Figs. 2
and 3.
p65-deficient Sensory Neurons Are Less Responsive
to Cytokines
To further investigate the role of NF-kB activation in
mediating the response of neurons to cytokines, we com-
pared the dose responses of nodose neurons obtained
from wild-type embryos and embryos that are homozy-
gous for a null mutation in the p65 gene (Beg et al., 1995).
The latest stage at which these experiments could be car-
ried out was E14 because p652/2 embryos die in utero
shortly after this stage. Although nodose neurons are max-
imally responsive to neurotrophic cytokines at late fetal
stages, a substantial proportion of these neurons survive in
response to cytokines at stages up to E14 (Horton et al.,
1998). For these experiments, adult p651/2 mice were
crossed and pregnant females were killed after 12- or 14-d
gestation and the nodose ganglia dissected out from the
embryos. Because of the small size of the nodose ganglia, a
rapid genotyping procedure was used so that the ganglia
from either wild-type or p652/2 embryos could be pooled
to obtain sufficient neurons for at least one dose response
in each experiment. Fig. 5 shows that p65-deficient nodose
neurons displayed a substantially reduced survival re-
sponse to LIF, CNTF, CT-1, and IL-6 compared with wild-
type embryos from the same litters. Although only either
Figure 2. Bar chart of the
number of E18 trigeminal
ganglion neurons surviving
24 h after injection with ei-
ther and empty pcDNAIII
plasmid (control and CNTF)
or the super-repressor IkB-a
plasmid (IkB and CNTF 1
IkB) expressed as a percent-
age of the number of injected
neurons. The mean and SEM
are shown for three separate
experiments.
Figure 3. Bar chart of the number of E18 nodose ganglion neu-
rons surviving 24 and 48 h after injection with either an empty
pcDNAIII plasmid (vector) or the super-repressor IkB-a plas-
mid (IkB) expressed as a percentage of the number of injected
neurons. The data from neurons grown separately with 50 ng/ml
CNTF, 50 ng/ml CT-1, 50 ng/ml LIF, and 10 ng/ml BDNF are
shown. The means and SEM of the results of five to ten separate
experiments for each factor are shown.Middleton et al. NF-kB Activation and Neuronal Survival 329
E12 or E14 data are illustrated for each cytokine, in sev-
eral experiments carried out at both ages, the survival of
p65-deficient neurons to each cytokine was markedly
lower than wild-type neurons throughout the broad con-
centration range studied. In the case of CNTF, where the
difference in survival between wild-type and p65-deficient
neurons was most pronounced, the number of wild-type
neurons surviving with CNTF was more than fivefold
greater than the number of p65-deficient neurons surviv-
ing with this factor over virtually the entire concentration
range. These results indicate that the absence of p65 sub-
stantially reduces the ability of neurotrophic cytokines to
promote the survival of developing nodose neurons. In
contrast to the markedly impaired survival response of
p65-deficient nodose neurons to cytokines, our previous
work on the response of p65-deficient neurons to neu-
rotrophins has demonstrated that the dose response of
p65-deficient nodose neurons to BDNF is completely nor-
mal (Hamanoue et al., 1999). This demonstrates that the
impaired survival response of p65-deficient nodose neu-
rons to cytokines is not some nonspecific detrimental ef-
fect of the lack of p65 on cell viability, but shows that p65
plays a highly selective role in mediating responses to cer-
tain neurotrophic factors.
Increased Apoptosis in the Nodose Ganglia of
p65-deficient Embryos
To determine if the reduced survival response of p65-defi-
cient nodose neurons to cytokines observed in vitro results
in increased death of these neurons in vivo, we counted
the total number of neurons in the nodose ganglia of wild-
type and p652/2 embryos and estimated the proportion of
neurons undergoing apoptosis at E14. Embryos were
fixed, embedded, and serially sectioned through the no-
dose ganglia and stained for neurofilament protein to pos-
itively identify all neurons. The number of neurons with
pyknotic nuclei and the total number of neurons were
counted in these sections. All histology slides were coded
so that these estimates were made without knowledge of
the genotype.
The number of cells undergoing apoptosis in the trigem-
inal ganglion was estimated by counting the number of
pyknotic nuclei that were recognized as one or more darkly
stained spherical structures contained within a clearly visi-
ble membrane. The great majority of pyknotic nuclei were
observed in large degenerating cells, suggesting that these
were neurons (Oppenheim, 1991). Fig. 6 shows that the
number of pyknotic nuclei in the nodose ganglia of E14
p652/2 embryos was almost threefold greater than in wild-
type embryos of the same age. There was also a 30% re-
duction in the total number of neurons in the nodose gan-
glia of p652/2 embryos at this age. The total number of
neurons in the nodose ganglia of p651/2 embryos was in-
termediate between the numbers in wild-type and p652/2
embryos, indicating a gene dosage effect. These results in-
dicate that the survival of p65-deficient nodose neurons is
impaired in vivo.
Cytokine Receptor Expression Is Unaffected in
p65-deficient Nodose Neurons
As NF-kB is a transcription factor that regulates the ex-
pression of many genes, it is possible that the reduced sur-
Figure 4. Graph of the number of E18 nodose ganglion neurons
surviving at 24 hourly intervals after LIF deprivation and injec-
tion with either an empty pcDNAIII plasmid (vector) or the p65
plasmid (p65) expressed as a percentage of the number of in-
jected neurons or resupplemented with LIF or CNTF. The means
and SEM are shown for three separate experiments.
Figure 5. Graphs of the dose responses of E12 or E14 nodose
neurons from wild-type and p652/2 embryos to LIF, CT-1, CNTF,
and IL-6. The means and standard errors of typical dose re-
sponses set up in triplicate are shown. The results of two to four
separate dose response experiments for each factor at each age
were very similar to the results illustrated.The Journal of Cell Biology, Volume 148, 2000 330
vival response of p65-deficient sensory neurons to cyto-
kines is not a direct consequence of p65 being an integral
component of a cytokine signaling pathway, but may be
secondary to a reduction in cytokine receptor expression.
There is evidence, for example, that NF-kB regulates the
expression of the IL-2 receptor (Cross et al., 1989). To ex-
plore the possibility that the selective reduction of the cy-
tokine survival responses in p65-deficient neurons might
be due to reduced expression of cytokine receptors, we
used immunocytochemistry to assess the proportion of
neurons that express cytokine receptor components in cul-
tures established from the nodose ganglia of E12 and E14
wild-type, p651/2, and p652/2 embryos. In these experi-
ments, dissociated cultures of nodose neurons were cul-
tured for six hours with a cocktail of cytokines and BDNF
to sustain the survival of the maximum number of neu-
rons. The cultures were then fixed and stained with anti-
bodies to gp130, LIFRb, CNTFRa, and IL-6Ra. Fig. 7
shows that the great majority of neurons exhibited positive
staining for each of these receptors and that the percent-
age stained for each receptor was almost identical in wild-
type and p65-deficient neurons. No neurons were stained
in cultures that were not incubated with primary antise-
rum, but otherwise, were processed normally. These find-
ings suggest that similar levels of cytokine receptors are
expressed in p65-deficient and wild-type nodose neurons
and that reduced receptor expression is unlikely to ac-
count for the decreased sensitivity of p65-deficient neu-
rons to cytokines.
Discussion
Using a variety of complementary experimental ap-
proaches, we have demonstrated that NF-kB plays a major
role in mediating the survival response of embryonic sen-
sory neurons to the neurotrophic cytokines, CNTF, LIF,
CT-1, and IL-6. First, CNTF causes a marked activation of
NF-kB in cultured trigeminal neurons. Second, preventing
CNTF-induced NF-kB activation in these neurons with su-
per-repressor IkBa causes a substantial reduction in the
survival response of these neurons to CNTF. Likewise, su-
per-repressor IkB causes a marked reduction in the sur-
vival response of nodose neurons to CNTF, LIF, and CT-1.
Third, nodose neurons from p652/2 embryos have a poor
survival response to these cytokines compared with neu-
rons from wild-type embryos. Fourth, increased numbers
of cytokine-dependent nodose neurons die by apoptosis in
p652/2 embryos in vivo. Expression of the super-repressor
IkB does not exert a nonspecific detrimental effect on
neuronal survival because it has no effect whatsoever on
the survival of nodose neurons grown with BDNF. Like-
wise, the poor survival of p65-deficient nodose neurons
with neurotrophic cytokines does not represent a nonspe-
cific detrimental effect of the absence of this protein on
cell survival because the dose response of these neurons to
BDNF is entirely normal. Furthermore, the selective re-
duction in the response of nodose neurons to cytokines is
not due to reduced expression of cytokine receptors be-
cause the proportion of nodose neurons that express cy-
tokine receptor subunits is completely unaffected by the
p65 null mutation.
Previous work has shown that NGF activates NF-kB in
developing sensory neurons by binding to the p75 neu-
rotrophin receptor and that inhibiting NF-kB activation
Figure 6. Bar charts of the number of pyknotic nuclei and total
numbers of neurons in the nodose ganglia of E14 wild-type, p651/2,
and p652/2 embryos. The means and standard errors of the data
obtained from five wild-type, seven p651/2, and seven p652/2 em-
bryos are shown.
Figure 7. Bar chart of the percentage of E14 nodose neurons in
short-term cultures established from wild-type, p651/2, and p652/2
embryos that are immunoreactive for gp130, LIFRb, CNTFRa,
and IL-6Ra. The means and standard errors of the percentage of
labeled neurons in quadruplicate wells for each data point in a
representative experiment are shown. Similar results were ob-
served in two additional experiments carried out at E12 and E14.Middleton et al. NF-kB Activation and Neuronal Survival 331
with super-repressor IkBa causes a small reduction in the
number of neurons surviving with NGF (Hamanoue et al.,
1999). In contrast, the level of NF-kB activation induced
by CNTF in the same sensory neurons is greater and the
decrease in the survival response to this and other neu-
rotrophic cytokines brought about by super-repressor IkB
is substantially greater. These findings, together with our
demonstration that the response of p65-deficient sensory
neurons to neurotrophic cytokines is markedly reduced,
indicate that NF-kB activation plays a much more promi-
nent role in mediating the survival response of developing
sensory neurons to cytokines than to NGF.
Although it has been established that binding of CNTF
to its receptor complex activates directly or indirectly a
number of signaling pathways, including the JAK-Stat,
PI-3 kinase, Ras/MAP kinase, and PLC-g pathways (Boul-
ton et al., 1994; Stahl et al., 1994; Frank et al., 1996), the
mechanism by which CNTF promotes neuronal survival is
not known. However, most signals that induce NF-kB do
so by activation of the IkB kinases a and b. The activated
kinases phosphorylate IkB-a on serines 32 and 36 leading
to recognition of phosphorylated IkB-a by an SCF ubiq-
uitin ligase complex containing bTrCP (Maniatis, 1999).
Studies with knockout mice have indicated that, whereas
IKKa appears to be involved in the development of skin
and skeleton, IKKb appears to participate in signaling me-
diated by the proinflammatory cytokines, TNFa and IL-1b
(May and Ghosh, 1999). As CNTF signaling is blocked by
the S32A/S36A mutant of IkBa that is unable to be phos-
phorylated by IKKa or IKKb, it seems likely that CNTF
signaling leads to activation of either IKKa or -b. In addi-
tion, it has recently been demonstrated that the PKB/Akt
protein kinase, activated by PI-3 kinase, directly phos-
phorylates and activates IKKa, leading to NF-kB activa-
tion (Ozes et al., 1999; Romashkova and Makarov, 1999).
Thus, a possible sequence of events after engagement of
CNTF by its receptor complex is activation of PI-3 kinase,
leading to activation of PKB/Akt, which in turn phos-
phorylates and activates IKKa, resulting in signal-induced
degradation of IkBa and release of active NF-kB.
In addition to promoting neuronal survival, CNTF has
many functions in different cell types, including regulation
of neuroblast and oligodendrocyte proliferation (Erns-
berger et al., 1989; Barres et al., 1996), neuropeptide and
neurotransmitter synthesis (Ernsberger et al., 1989; Rao
et al., 1992; Louis et al., 1993), rod cell differentiation
(Fuhrmann et al., 1998), and induction of acute phase pro-
teins in hepatocytes (Schooltink et al., 1992). It has yet to
be ascertained which of the signaling pathways activated
by CNTF mediate each of these cellular responses. Al-
though LIF has been shown to activate NF-kB in phago-
cytes (Gruss et al., 1992), we have shown for the first time
that CNTF activates NF-kB in neurons and that this plays
a major role in mediating the trophic actions of this and
other cytokines.
Although the mechanism by which NF-kB activation
promotes the survival of cytokine-dependent developing
sensory neurons is unknown, there is growing evidence
that NF-kB induces the expression of several genes encod-
ing proteins that oppose the cell death program. It appears
that prevention of TNFa-mediated apoptosis by NF-kB is
a direct consequence of increased expression of genes en-
coding TRAF1, TRAF2, c-IAP1, and c-IAP2, which block
caspase 8 activation (Chu et al., 1997; Wang et al., 1998).
Two other genes that appear to be important in protecting
cells from TNF-induced apoptosis, A20 and IEX-1L, are
also direct transcriptional targets of NF-kB (Krikos et al.,
1992; Wu et al., 1998). NF-kB induces expression of the
Bcl-2 homolog A1 in B and T cells, which is critical for sur-
vival during lymphocyte activation (Grumont et al., 1999;
Zong et al., 1999), and NF-kB–mediated induction of Bcl-2
and Bcl-x also plays a role in the neuroprotective action
of TNF against hypoxia- or nitric oxide-induced injury
(Tamatani et al., 1999).
In summary, we have provided the first evidence that
NF-kB plays a major role in mediating the neurotrophic
actions of cytokines. These findings not only have implica-
tions for understanding survival signaling in neurons dur-
ing the critical stages of development when connections
are being established, but raise questions about the impor-
tance of NF-kB for sustaining the survival of mature neu-
rons and in neurodegenerative diseases.
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